THE BIG LONG! Vaccine for the Covid-Mutants! :-)
ENTRY: 44.20 EUR
TARGET: 90.00 EUR (104 % profit)
STOP: 32.40 EUR
- This is only an interim analysis result of the CUREVAC Covid vaccince!!
- Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues.
- The vaccine candidate is in the final stage of clinical development.
- CEO Franz-Werner Haas announced that one had hoped for stronger results in the interim analysis.
- But continue the current study until the final analysis.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。